Scientific program
(Last update: August 2009 | subject to change)
| Thursday, 29 October 2009 | |
|---|---|
| 08.50-09.00 am | Welcome Walter Brehm (Leipzig, Germany)/Roger Smith (London, UK) |
| 09.00-09.30 am | Keynote lecture: Stem cell therapy for tissue repair: The stem cell host-interaction Frank Barry (Galway, Ireland) |
| Embryonic stem cells | |
| 09.30-10.00 am | Equine embryonic and iPS stem cells Lisa Fortier (Cornell, USA) |
| 10.00-10.30 am | Establishing an equine embryonic stem cell line Debbie Guest (Newmarket, UK) |
| 10.30-11.00 am | Coffee Break |
| Mesenchymal stem cells | |
| 11.00-11.30 am | Defining equine mesenchymal stem cells in vitro Peter Clegg (Liverpool, UK) |
| 11.30 am -12.00 pm | Expansion of equine mesenchymal stem cells on fibrinogen-rich protein surfaces derived from blood plasma John Kisiday (Colorado, USA) |
| 12.00-12.30 pm | Optimising the recovery of mesenchymal progenitor cells from bone marrow Yoshinori Kasashima (Utsunomiya, Japan) |
| 12.30-2.00 pm | Lunch Break / Poster Session |
| Stem cells for tendon regeneration | |
| 2.00-2.30 pm | Effect of tendon-derived progenitor cells on a collagenase-induced model of tendinitis in horses Allison Stewart (Illinois, USA) |
| 2.30-3.00 pm | Effectiveness of bone-marrow derived mesenchymal progenitor cells for naturally-occurring tendinopathy in the horse Roger Smith (London, UK) |
| 3.00-3.15 pm | The equine periodontal ligament: a source of mesenchymal stem cells for regenerative therapies in the horse? Carsten Staszyk (Hannover, Germany) |
| 3.15-4.00 pm | Coffee Break / Poster Session |
| 4.00-4.30 pm | Fat-derived MSCs for equine tendon repair Linda Dahlgren (Blacksburg, USA) |
| 4.30-5.00 pm | Ultrasonographic, MRI and histological evaluation of a new tendonitis model in the superficial digital flexor tendon of horses Michael Schramme (North Carolina, USA) |
| 5.00-5.15 pm | Management of equine tendon and ligament injuries with expanded autologous adipose-derived mesenchymal stem cells – a clinical study Minna Leppänen (Kangasala, Finland) |
| 5.15-5.30 pm | Follow-up of recovery of equine tendon and ligament injuries 18-24 months after treatment with enriched autologous adipose-derived mesenchymal stem cells – a clinical study Minna Leppänen (Kangasala, Finland) |
| 5.30-6.30 pm | Opening ceremony of the World Conference on Regenerative Medicine (WRM) |
| 6.30-10.00 pm | Get-together in Exhibition Area of WRM |
| Friday, 30 October 2009 | |
| 09.00-09.30 am | Keynote lecture: Development of cell based strategies in the management of orthopaedic conditions - Needs in the human and animals Allen Goodship (London, UK) |
| Stem cells for joint regeneration | |
| 09.30-10.00 am | Clinical evaluation of bone marrow-derived MSCs in naturally-occurring joint disease David Frisbie (Colorado, USA) |
| 10.00-10.30 am | Stem cells for cartilage repair in vitro Walter Brehm (Leipzig, Germany) |
| 10.30-11.00 am | Coffee Break / Poster Session |
| Stem cells for bone regeneration | |
| 11.00-11.30 am | Osteoprogenitors in bone repair Laurie McDuffee (Prince Edward Island, Canada) |
| 11.30 am -12.00 pm | Experimental and clinical application of BMSCs for the treatment of large bone defects in animals Antonio Crovace (Bari, Italy) |
| 12.00-12.15 pm | Autologous stem cell therapy (ASCT) for the treatment of bone fractures in cat: A case report Leandro Gardel (Porto, Portugal) |
| 12.15-12.30 pm | Implantation of autologous bone marrow mononuclear cells as a minimal invasive therapy of Legg-Calvè-Perthès’ Disease in the dog Antonio Crovace (Bari, Italy) |
| 12.30-2.00 pm | Lunch Break / Poster Session |
| Cell –based therapies/endogenous stem cells | |
| 2.00-2.30 pm | Cell-based therapy without cells: The effect of Platelet Rich Plasma (PRP) on the healing of artificially created tendon lesion in the horse Rene van Weeren (Utrecht, The Netherlands) |
| 2.30-3.00 pm | Olfactory ensheathing cell transplantation for treatment of severe spinal cord injury in dogs Nick Jeffery (Cambridge, UK) |
| 3.00-3.30 pm | Transgene-induced reprogramming of equine fibroblasts Xavier Donadeu (Edinburgh, UK) |
| 3.30-4.00 pm | Coffee Break |
| 4.00-4.30 pm | Marker tolerance: A new tool in regenerative medicine and cell tracking Reinhold Erben (Vienna, Austria) |
| 4.30-5.00 pm | Umbilical cord blood and umbilical cord matrix - A comparison of two potential MSC sources Iris Ribitsch (Leipzig, Germany) |
| 5.00-5.30 pm | Veterinary Stem Cell Therapy: A Regulatory Approach to Regenerative Veterinary Medicine in the EU and the U.S. Karl Nobert (New York, USA) |
| 5.30-5.45 pm | Increased WNT and notch signalling in activated canine liver progenitor cells Louis Penning (Utrecht, The Netherlands) |
| 5.45-6.00 pm | Isolation and chrondrogenic differentiation of cells isolated from equine synovial fluid Matthew Stewart (Illinois, USA) |
| 7.00 pm | Social evening |